Search Ontology:
ChEBI

gadoterate meglumine

Term ID
CHEBI:73727
Synonyms
  • 1-deoxy-1-(methylazaniumyl)-D-glucitol [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(4-)]gadolinate(1-)
  • [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(3-)]gadolinium--1-deoxy-1-(methylamino)-D-glucitol (1/1)
  • Gadolinium-DOTA meglumine
  • Gd-DOTA meglumine
  • Meglumine gadopentate
  • Meglumine gadoterate
Definition
An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_part
has_role
Phenotype
Phenotype resulting from gadoterate meglumine
Phenotype where environments contain gadoterate meglumine
Phenotype modified by environments containing gadoterate meglumine
Human Disease / Model Data